Sangamo Biosciences (SGMO) Misses Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. MSFT
3. SPY
4. CSCO
5. KTOS
6. PLTR
7. NVDA
8. META
9. HOOD
10. AMZN

Go back to Sangamo Biosciences (SGMO) Misses Q2 EPS by 4c

Wedbush Recommends Buying Sangamo BioSciences (SGMO) on Weakness

August 6, 2015 1:07 PM EDT

Wedbush analyst Liana Moussatos is out defending Sangamo BioSciences (NASDAQ: SGMO) mid-day with shares getting sliced to the tune of 16% following Q2 results that missed the Street. The analyst notes the $218 million cash on hand is enough to cover significant clinical progress and they recommend buying the stock on weakness.

"We anticipate significant clinical progress in the next 6- 18 months," Moussatos... More